Biomarkers in colorectal cancer: Current clinical utility and future perspectives
RESISTANCE TO ANTI-EGFR THERAPIES IN COLORECTAL CANCER – Sanguine Bio Researcher Blog
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies | Journal of Experimental & Clinical Cancer Research | Full Text
Hexameric procyanidins inhibit colorectal cancer cell growth through both redox and non-redox regulation of the epidermal growth factor signaling pathway - ScienceDirect
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives - Annals of Oncology
Mechanisms of resistance to anti-EGFR therapy in colorectal cancer. - Abstract - Europe PMC
Frontiers | The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy
Polarization of macrophages in the tumor microenvironment is influenced by EGFR signaling within colon cancer cells | Oncotarget
![PDF] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2e5f89dec8a25afc1d61dc3d7197afa33839845d/3-Figure2-1.png "PDF] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar")
PDF] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar
Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer | Aging
Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic
IJMS | Free Full-Text | Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
Different EGFR signalling pathways induced by the interaction between... | Download Scientific Diagram
Clinical management of metastatic colorectal cancer in the era of precision medicine - Ciardiello - 2022 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Y‑box‑binding protein 1 inhibits apoptosis and upregulates EGFR in colon cancer
Epidermal growth factor receptor (EGFR)-related signaling pathway in... | Download Scientific Diagram
Cancers | Free Full-Text | Immune Resistance and EGFR Antagonists in Colorectal Cancer
Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution - ScienceDirect
Molecular Markers for the Prediction of Anti-EGFR Monoclonal Antibody Treatment Efficacy in Metastatic Colorectal Cancer
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
Feedback activation of EGFR/wild-type RAS signaling axis limits KRASG12D inhibitor efficacy in KRASG12D-mutated colorectal cancer | Oncogene
New combination therapy offers bowel cancer patients extra treatment option
Biomarkers in Targeted Therapy for Colorectal Cancer
Toward an individualizing therapy for colorectal cancer: the example of the anti-EGFR monoclonal antibodies | Personalized Medicine
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study - The Lancet Oncology
